HPV infections in transgender people: a hidden health gap gets a closer look
NCT ID NCT05981807
First seen Sep 02, 2026 · Last updated Sep 03, 2026 · Updated 1 time
Summary
This observational study measures how often HPV infections and other sexually transmitted infections occur in transgender adults. Researchers will check for HPV at genital, anal, and oral sites, and also look for anal dysplasia, which can be a precursor to cancer. The study includes 200 transgender people aged 18 and older who have not been vaccinated against HPV. The goal is to understand infection rates overall and by HIV status, which may help shape future screening and prevention efforts.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If this study succeeds, it could reveal how common HPV infections are in transgender people, guiding better screening and prevention strategies for this group.
- What could go wrong
- This is an observational study, so it cannot test treatments. The findings may not apply to all transgender people, and the study does not follow participants over time to see how infections change.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
200 people
The number who actually took part.
- Started
-
Oct 2024
- Finished
-
Jun 2025
- Lead sponsor
-
A government agency
The lead sponsor is a government body.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
The study will include people who belong to the transgender population : i.e. people who do not identify to the gender assigned at birth (man to woman and woman to man).
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion criteria: * Age ≥ 18 years * To belong to transgender population : i.e. people who doesn't identify to the gender assigned at birth * To be affiliated to a social security system or be beneficiary of AME Exclusion criteria: * To have ever been vaccinated against HPV * Research participation refusal * People under guardianship or curatorship, or deprived of liberty by administrative or judiciary measure
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Human immunodeficiency virus infection are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Bichat Hospital
Paris, 75015, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A gel that could help the cervix heal from HPV?
- A tablet tool may empower women to prevent HIV — trial puts it to the test
- A Two-Pronged immune attack against HPV: could it prevent cervical cancer?
- Could fewer HPV vaccine doses offer lasting protection?
- Better swab, better catch: study aims to sharpen anal cancer screening
- Peer navigators and mobile clinics aim to slash HIV rates in rural south african youth